↓ Skip to main content

Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways

Overview of attention for article published in Molecular Cancer, March 2017
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

wikipedia
3 Wikipedia pages

Readers on

mendeley
162 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways
Published in
Molecular Cancer, March 2017
DOI 10.1186/s12943-017-0621-z
Pubmed ID
Authors

Sherif Abdelaziz Ibrahim, Ramy Gadalla, Eslam A. El-Ghonaimy, Omnia Samir, Hossam Taha Mohamed, Hebatallah Hassan, Burkhard Greve, Mohamed El-Shinawi, Mona Mostafa Mohamed, Martin Götte

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 162 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 162 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 22 14%
Student > Ph. D. Student 20 12%
Student > Bachelor 20 12%
Researcher 19 12%
Student > Doctoral Student 7 4%
Other 22 14%
Unknown 52 32%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 50 31%
Medicine and Dentistry 20 12%
Agricultural and Biological Sciences 7 4%
Pharmacology, Toxicology and Pharmaceutical Science 5 3%
Computer Science 4 2%
Other 15 9%
Unknown 61 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 December 2023.
All research outputs
#7,658,109
of 23,313,051 outputs
Outputs from Molecular Cancer
#565
of 1,756 outputs
Outputs of similar age
#121,687
of 308,785 outputs
Outputs of similar age from Molecular Cancer
#16
of 49 outputs
Altmetric has tracked 23,313,051 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,756 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one has gotten more attention than average, scoring higher than 54% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 308,785 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.